A Phase <scp>II</scp> Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With SynovitisRoy Fleischmann, Marc C. Levesque, Francisco J. Blanco et al.|Arthritis & Rheumatology|2019Cited by 209